Rapid increase in serum levels of matrix metalloproteinase-9 (MMP-9) postoperatively is associated with a decrease in the amount of intracellular MMP-9

Surgical Innovation

Volumn 12, Issue 4, 2005, Pages 333-337

  Belizon, Avraham ^a   Kirman, Irena ^a   Karten, Moshe ^a   Jain, Suvinit ^a   Whelan, Richard L ^a  

^a Columbia University ^*  (United States)

Author keywords

Insulin like growth factor binding protein; Laparotomy; Matrix metalloproteinase 9; Tumor growth

Indexed keywords

GELATINASE B; KETAMINE; SOMATOMEDIN BINDING PROTEIN 3; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CELL LEVEL; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; FEMALE; GENERAL ANESTHESIA; LAPAROTOMY; MONONUCLEAR CELL; MOUSE; NONHUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRETEST POSTTEST DESIGN; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; VEIN PUNCTURE; ZYMOGRAPHY;

ANIMALS; FEMALE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INTRACELLULAR FLUID; LAPAROTOMY; LEUKOCYTES, MONONUCLEAR; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, TRANSGENIC; POSTOPERATIVE PERIOD;

EID: 32044462462     PISSN: 15533506     EISSN: None     Source Type: Journal    
DOI: 10.1177/155335060501200408     Document Type: Article

References (23)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 49:33-64, 1999.
2. Vermoken JB, Claessen AM, van Tinteren H, et al: Active specific immunotherapy for stage 2 and stage 3 human colon cancer: a randomized trial. Lancet 353:345-350, 1999.
3. Jagoditsch M, Lisborg PH, Jatzgo GR, et al: Long-term prognosis for colon cancer related to consistent radical surgery: multivariate analysis of clinical, surgical and pathologic variables. World J Surg 24:1264-1270, 2000.
4. Weese JL, Ottery FD, Emoto SE: Do operations facilitate tumor growth? An experimental model in rats. Surgery 100:273-277, 1986.
5. 2 pneumoperitoneum and the inhibition of metastases utilizing perioperative immunomodulation and a tumor vaccine. Surg Endosc 16:1162-1169, 2002.
6. Lee SW, Gleason N, Blanco I, et al: Higher colon cancer tumor proliferative index and lower tumor cell death rate in mice undergoing laparotomy versus insufflation. Surg Endosc 16:36-39, 2002.
7. 2 pneumoperitoneum. Dis Colon Rectum 42:477-481, 1999.
8. Allendorf JD, Bessler M, Kayton ML, et al: Increased tumor establishment and growth after laparotomy vs laparoscopy in a murine model. Arch Surg 130:649-653, 1995.
9. Kirman I, Cekic V, Poltaratskaia N, et al: Plasma from patients undergoing major open surgery stimulates in vitro tumor growth: lower insulin-like growth factor binding protein 3 levels may, in part, account for this change. Surgery 132:186-192, 2002.
10. Martin JL, Baxter RC: Insulin-like growth factor-binding protein from human plasma. Purification and characterization. J Biol Chem261:8754-8760, 1986.
11. Valentinis B, Bhala A, DeAngelis T, et al: The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9:361-367, 1995.
12. Lee, HY, Chun, KH, Liu, B, et al: Insulin-like growth factor-binding protein-3 inhibits the growth of non-small cell lung cancer. Cancer Res 62: 3530-3537, 2002.
13. Chambers AF, Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89:1260-1270, 1997.
14. Waas ET, Wobbes T, Lomme RM et al: Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis. Br J Surg 90:1556-1564, 2003.
15. Lee SW, Feingold DL, Carter JJ, et al: Peritoneal macrophage and blood monocyte functions after open and laparoscopic-assisted cecectomy in rats. Surg Endosc 17:1996-2002, 2003.
16. Owen CA, Hu Z, Barrick B, Shapiro SD: Inducible expression of tissue inhibitor of metalloproteinases-resistant matrix metalloproteinase-9 on the cell surface of neutrophils. Am J Respir Cell Mol Biol 29:283-294, 2003.
17. Allendorf JD, Bessler M, Horvath KD, et al: Increased tumor establishment and growth after open vs laparoscopic bowel resection in mice. Surg Endosc 12:1035-1038, 1998.
18. Da Costa ML, Redmond P, Bouchier-Hayes DJ: The effect of laparotomy and laparoscopy on the establishment of spontaneous tumor metastases. Surgery 124:516-525, 1998.
19. Carter JJ, Feingold DL, Kirman I, et al: Laparoscopic-assisted cecectomy is associated with decreased formation of postoperative pulmonary metastases compared with open cecectomy in a murine model. Surgery 134:432-436, 2003.
20. Lacy AM, Garcia-Valdecasas JC, Delgado S, et al: Laparoscopy-assisted colectomy versus open colectomy for treatment of non metastatic colon cancer: a randomized trial. Lancet 359:2224-2229, 2002.
21. Holmgren L, O'Reilly MS, Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149-153, 1995.
22. O'reilly MS, Boehm T, Shing Y, et al: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285, 1997.
23. Kirman I, Poltoratskaia N, Sylla P, Whelan RL: Insulin-like growth factor-binding protein 3 inhibits growth of experimental colocarcinoma. Surgery 136:205-209, 2004.